PCNA, proliferating cell nuclear antigen, 5111

N. diseases: 581; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0206368
Disease: Exfoliation Syndrome
Exfoliation Syndrome
0.010 Biomarker disease BEFREE <b>Purpose</b>: This study aims to determine the expression patterns of terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL), proliferating cell nuclear antigen (PCNA) and SOX2 in lens epithelial cells (LEC) of cataract patients with pseudoexfoliation syndrome (PEX), and to determine the effect of apoptosis, proliferative activity and stem/progenitor cells on cataract formation in patients with PEX. 31424957 2020
CUI: C0010674
Disease: Cystic Fibrosis
Cystic Fibrosis
0.010 Biomarker disease BEFREE Moreover, PCNA positivity in the crypts of CF mice was alleviated by LiCl, which activates Wnt/β-catenin signaling. 30639531 2019
CUI: C0013390
Disease: Dysmenorrhea
Dysmenorrhea
0.010 Biomarker phenotype BEFREE Additionally, these histopathological changes and PCNA and CD34 immunoreactivity were significantly correlated with the persistence of NCPP and dysmenorrhea. 29642800 2019
CUI: C0014474
Disease: Ependymoma
Ependymoma
0.010 Biomarker disease BEFREE In addition, 6 hub genes [cyclin dependent kinase 1, CD44 molecule (Indian blood group) (<i>CD44</i>), proliferating cell nuclear antigen (<i>PCNA</i>), <i>MYC</i>, synaptotagmin 1 (<i>SYT1</i>) and kinesin family member 4A] and 6 crucial miRNAs [<i>homo sapiens (hsa)-miR-34a-5p, hsa-miR-449a, hsa-miR-106a-5p, hsa-miR-124-3p, hsa-miR-128-3p</i> and <i>hsa-miR-330-3p</i>] were identified as biomarkers and potential therapeutic targets for EPN. 31788082 2019
CUI: C0020502
Disease: Hyperparathyroidism
Hyperparathyroidism
0.010 AlteredExpression disease BEFREE In primary cultured PTG tissues, HPi induced intact parathyroid hormone (iPTH) secretion, proliferating cell nuclear antigen (PCNA) expression and COX2 activity, while COX2 and EP2 inhibitors attenuated hyperparathyroidism promoted by HPi. 29982796 2019
CUI: C0022658
Disease: Kidney Diseases
Kidney Diseases
0.010 Biomarker group BEFREE Proliferating cell nuclear antigen (PCNA)-, cyclin-dependent kinase 4 (CDK4)-, and Cyclin D1-positive podocytes were found in mice with adriamycin-induced nephropathy. 31801948 2019
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.010 Biomarker disease BEFREE IL17C transcripts showed the strongest negative correlation to PCNA in both ATL cohorts, which was replicated in two large cohorts of T- and B-cell acute lymphoid leukemia (ALL). 30303535 2019
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Moreover, proliferating cell nuclear antigen (PCNA) and CD34 immunoreactivity in both glandular and stromal cells and vascular endothelium were significantly higher in patients with pain persistence ( P = .0079 and P = .0025, respectively). 29642800 2019
CUI: C0037286
Disease: Skin Neoplasms
Skin Neoplasms
0.010 AlteredExpression group BEFREE Its efficacy extended to a reduction in the relative tumor weight with 1.70 and 1.51-fold compared to positive control and free ETD, that manifested by a 1.72-fold reduction in both COX-2 and proliferating cell nuclear antigen mRNA (PCNA-mRNA) levels and 2.63-fold elevation in caspase-3 level in skin tumors relative to the positive control group with no hepato-and nephrotoxicity. 31571864 2019
CUI: C0149782
Disease: Squamous cell carcinoma of lung
Squamous cell carcinoma of lung
0.010 AlteredExpression disease BEFREE Gephyrin overexpression suppressed LUSC cell proliferation, arrested cell cycle progression, and decreased the expression of cell-cycle related proteins such as cyclin D1, cyclin-dependent kinase-2 (CDK2), and proliferation-related protein proliferating cell nuclear antigen (PCNA). 31239782 2019
Secondary malignant neoplasm of lung
0.010 AlteredExpression disease BEFREE The proliferating cell nuclear antigen (PCNA) expression was tested by immunohistochemical staining, and the lung metastasis was observed by H&E staining. miR-7 expression was decreased and methylation state of miR-7 was increased in OS tissues and cells. 31102265 2019
CUI: C0206698
Disease: Cholangiocarcinoma
Cholangiocarcinoma
0.010 Biomarker disease BEFREE Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity. 31077409 2019
Persistent Hyperplastic Primary Vitreous
0.010 Biomarker disease BEFREE <b>Abbreviations</b>: ACTB: actin, beta; CCND3: cyclin 3; CDK6: cyclin-dependent kinase 6; CHQ: chloroquine; COL4A1: collagen, type IV, alpha 1; CRYBA1: crystallin, beta A1; DAPI: 4'6-diamino-2-phenylindole; EGFR: epidermal growth factor receptor; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GFAP: glial fibrillary growth factor; KDR: kinase insert domain protein receptor; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MKI67: antigen identified by monoclonal antibody Ki 67; MTORC1: mechanistic target of rapamycin kinase complex 1; PARP: poly (ADP-ribose) polymerase family; PCNA: proliferating cell nuclear antigen; PFV: persistent fetal vasculature; PHPV: persistent hyperplastic primary vitreous; RPE: retinal pigmented epithelium; RPS6: ribosomal protein S6; RPS6KB1: ribosomal protein S6 kinase, polypeptide 1; SQSTM1/p62: sequestome 1; TUBB: tubulin, beta; VCL: vinculin; VEGFA: vascular endothelial growth factor A; WT: wild type. 31462148 2019
CUI: C0333293
Disease: Healing ulcer
Healing ulcer
0.010 AlteredExpression disease BEFREE The ulcer healing activity was also associated with significant increases in gastric mucin content, collagen deposition, number of cells with positive marking for proliferating cell nuclear antigen (PCNA), and by changes in the expression of the inflammatory parameters tumor necrosis factor (TNF)-α, interleukin (IL)-1β and cyclooxygenase (COX)-2, as well as a decrease of metalloproteinases (MMP-9 and MMP-2) activity. 30991046 2019
CUI: C0342649
Disease: Vascular calcification
Vascular calcification
0.010 AlteredExpression phenotype BEFREE Si-WNT8b reduced the levels of WNT8b, frizzled-4, β-catenin, phospho-GSK-3β (p-GSK-3β), and cyclin-D, whereas it increased the levels of p-β-catenin and GSK-3β, indicating that si-WNT8b could alter the Wnt-β-catenin signaling pathway and thus hamper the VC in T/G HA-VSMC, which was further demonstrated by the TOP/FOP-Flash assay and detection of the β-catenin expression level in the nucleus. 30461014 2019
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.010 AlteredExpression disease BEFREE RSV significantly suppressed tumor growth in vivo and decreased the proportion of cells showing expression of proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin (α-SMA). 31013842 2019
CUI: C0577631
Disease: Carotid Atherosclerosis
Carotid Atherosclerosis
0.010 Biomarker disease BEFREE In contrast, Uox-KO mice with carotid atherosclerosis showed severe neointimal changes in histology staining consistent with increases in intimal area and increases in proliferating cell nuclear antigen (PCNA)- and F4/80-positive cells. 30690853 2019
CUI: C0598766
Disease: Leukemogenesis
Leukemogenesis
0.010 AlteredExpression disease BEFREE These results suggest that BCR-ABL induces tyrosine phosphorylation of YAP presumably through Src family kinases, which results in expression of Survivin and Cyclin D leading to leukemogenesis in CML cells. 31428968 2019
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion
0.010 Biomarker disease BEFREE Similarly, more PCNA<sup>+</sup>NG2<sup>+</sup> cells were observed in the subventricular zone and white matter areas in the melatonin group compared with the MCAO group (P <  0.01). 31158461 2019
CUI: C0740457
Disease: Malignant neoplasm of kidney
Malignant neoplasm of kidney
0.010 Biomarker disease BEFREE Disease-free survival curves of Kif11 with different cancers and the relationships between Kif11 and the von Hippel-Lindau disease tumour suppressor gene (<i>VHL</i>), and proliferating cell nuclear antigen (PCNA) in kidney cancer were further analysed using the GEPIA database. 30819726 2019
CUI: C1378703
Disease: Renal carcinoma
Renal carcinoma
0.010 Biomarker disease BEFREE Disease-free survival curves of Kif11 with different cancers and the relationships between Kif11 and the von Hippel-Lindau disease tumour suppressor gene (<i>VHL</i>), and proliferating cell nuclear antigen (PCNA) in kidney cancer were further analysed using the GEPIA database. 30819726 2019
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.010 Biomarker phenotype BEFREE Cell apoptosis, proliferation or tumor angiogenesis were examined via immunohistochemical (IHC) staining for transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL), proliferating cell nuclear antigen (PCNA) or cluster of differentiation 31 (CD31), respectively. 30810974 2019
POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE
0.010 AlteredExpression disease BEFREE We found an increase in PCNA expression, which correlates with cytoplasmic accumulation of the polarization marker, EZRIN, in the BPS treated groups. 30654004 2019
Precursor Cell Lymphoblastic Leukemia Lymphoma
0.010 Biomarker disease BEFREE IL17C transcripts showed the strongest negative correlation to PCNA in both ATL cohorts, which was replicated in two large cohorts of T- and B-cell acute lymphoid leukemia (ALL). 30303535 2019
CUI: C0007140
Disease: Carcinosarcoma
Carcinosarcoma
0.010 AlteredExpression disease BEFREE We report the prognostic significance of bcl-2 and PCNA expression in canine mammary carcinosarcomas. 29565181 2018